Canadian Business Opportunities

Canadian Business
Partner with Apotex

Apotex is ranked 7th in the global generic pharmaceutical market and first in Canada for prescriptions filled, sales volume and value.

We are a vertically integrated company with expertise in API & finished dosage forms that have earned a reputation for providing customers and patients with affordable, high quality medicines.

We aspire to become of Partner of Choice with select third parties where they can offer:

  • Early to market opportunities
    • first-to-file
    • non-infringing API and/or formulations
    • NCE-1s
  • Currently approved and/or filed products
  • Contract development and/or manufacturing
  • New Technologies

Dosage Forms Apotex does not currently manufacture:


  • Dry Powder Inhalers
  • Metered Dose Inhalers


  • Nano particles
  • Carbapenems
  • Depots/ Long Acting injectables
  • Hormones
  • Liposomal
  • Lyophilized
  • Penicillins
  • Semi-Synthetic Penicillins
  • Pre-filled Syringes

Schedule II controlled drugs (USA only)

  • Creams
  • Gels
  • Ointments
  • Lotions


  • Ointments and gels


  • Orodispersable
  • Hormones
  • Buccal/transmucosals
  • Soft and Hard gelatin capsules

Apotex has substantial experience and expertise in identifying, developing, registering and litigating early-to-market products including Paragraph IV opportunities.

In addition to in-licensing, Apotex co-develops certain dosage forms and products where there is an opportunity for Apotex to contribute to the formulation, analytical development or clinical development.